A carregar...

Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis

Paricalcitol and cinacalcet have been recommended to reduce parathyroid hormone (PTH) levels for patients with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD), and they are able to reduce the risk of hypercalcemia and hyperphosphatemia. However, to date, it has remained uncerta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Xu, Wei, Gong, Lifeng, Lu, Jingkui, Tang, Weigang
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444362/
https://ncbi.nlm.nih.gov/pubmed/32855693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!